Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosaminoglycan (GAG) fibers are fibrous structures primarily composed of long, unbranched polysaccharides consisting of repeating disaccharide units. They are key components of the extracellular matrix in connective tissues, providing structural support, hydration, and mechanical resilience. Major types include hyaluronate, chondroitin sulfate, heparin, and keratan sulfate. While not direct drug targets themselves, their synthesis and degradation are implicated in various diseases, and some GAGs (e.g., heparin) are used as drugs. Defects in GAG metabolism lead to mucopolysaccharidoses.
N/A (structural component, not a direct drug target)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosaminoglycan Fibers (GAG Fibers).